Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.61−0.19 (-3.96%)
Close on Nov 17, 2026Market cap $57.89MP/E –Yield –
Neuraxis ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Neuraxis's ebitda for the twelve months ending Jun 30, 2026 was -$7.61M. For fiscal 2025 it was -$7.77M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.77M | – |
| FY2024 | Dec 31, 2024 | -$7.12M | – |
| FY2023 | Dec 31, 2023 | -$6.62M | – |
| FY2022 | Dec 31, 2022 | -$3.34M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.11M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.72M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.08M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.70M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.29M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.46M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.64M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.82M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.61M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.01M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.11M | – |
| Q1 FY2023 | Mar 31, 2023 | -$886.43K | – |
| Q4 FY2022 | Dec 31, 2022 | -$974.14K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.19M | – |
See a number that looks wrong?